PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 6 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
A pilot study found that a combination of sesamin and Schisandra extract reduced blood passage time by 9.0% at 1 week and 9.7% at 2 weeks [PMID:18317575].
In HepG2 cells and diet-induced obese mice, 1% Schisandra chinensis berry ethanol extract reduced lipid accumulation and decreased body and liver weights [PMID:29173646].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 28646833 (2017) — The use of fruit extracts for production of apple chips with enhanced antioxidant activity. · Roczniki Panstwowego Zakladu Higieny
- 2.PMID: 29173646 (2017) — Schisandra chinensis berry extract protects against steatosis by inhibiting histone acetylation in oleic acid-treated HepG2 cells and in the livers of diet-induced obese mice. · Nutrition research (New York, N.Y.)
- 3.PMID: 18317575 (2008) — Evaluation on the combined effect of Sesamin and Schisandra extract on blood fluidity. · Bioinformation
- 4.PMID: 23920279 (2013) — Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 22347152